Cancer Biology & Therapy

Papers
(The TQCC of Cancer Biology & Therapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma98
Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor85
Correction71
A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer66
Advances in natural killer cell immunotherapy for hematologic malignancies64
A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy57
Impact of leucine-rich diet on placenta's proteomic and metabolomic profiles of pregnant tumor-bearing rats50
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway49
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results47
Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis46
Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides45
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1843
Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment‎39
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article39
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition38
Immunotherapy resistance in solid tumors: mechanisms and potential solutions33
Advancements in exosome-based cancer diagnosis: from chipsets to nano vaccine32
The MYBL2-GTSE1 axis promotes laryngeal squamous cell carcinoma progression by regulating PI3K/AKT-dependent glycolytic reprogramming31
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells31
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT330
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression29
Protein lactylation: molecular mechanisms underlying lactate-driven tumorigenesis and cancer progression29
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer27
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer26
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells26
Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation26
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance25
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer25
Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy25
Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD25
LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K/Akt s24
Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids24
USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination23
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence23
NRSN2 promotes the malignant behavior of HPV-transfected laryngeal carcinoma cells through AMPK/ULK1 pathway mediated autophagy activation22
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007–2023)22
Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats22
PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness21
Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis21
CDH2 and CDH13 as potential prognostic and therapeutic targets for adrenocortical carcinoma21
Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-neg21
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma20
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma20
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma19
A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer19
Correction19
Robust prediction of glioma prognosis by hypoxia-induced ferroptosis genes: VEGFA-XBP1 co-expression for salvage therapy18
Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF918
Lenvatinib potentiates the antitumor efficacy of combined radiotherapy and PD-L1 blockade in lung adenocarcinoma18
Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology17
The critical role of tumor microbiome in cancer immunotherapy17
Neoplastic CD3⁺ B cells remodel the DLBCL tumor microenvironment via single-cell and spatial transcriptomics17
SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p16
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma16
Loss of ACSL1 fuels ferroptosis resistance in clear cell renal carcinoma16
Highly enriched exosomal lncRNA OIP5-AS1 regulates gastrointestinal stromal tumor (GIST) resistance to sunitinib through miR-145 and SOX916
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer15
CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells15
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy15
High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting15
Potential therapeutic GSK-3β inhibitor 9-ING-41 is active in combination with venetoclax in double-hit lymphoma (DHL)15
PI3Kγ inhibition drives M1 macrophage differentiation and synergizes with PD-L1 blockade to improve survival in poorly immunogenic head and neck squamous cell carcinoma14
Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing14
The anticancer mechanisms of Toxoplasma gondii rhoptry protein 16 on lung adenocarcinoma cells14
Correction13
MiR-378a-5p exerts a radiosensitizing effect on CRC through LRP8/β-catenin axis13
Lenvatinib promotes hepatocellular carcinoma pyroptosis by regulating GSDME palmitoylation13
Prognostic value of pretreatment procalcitonin and neutrophil–lymphocyte ratio in extensive-stage small-cell lung cancer13
Nuclear translocation of Cx43 promotes to CRC progression and associates with β-catenin accumulation13
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα13
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin13
DLAT promotes triple-negative breast cancer progression via YAP1 activation13
Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression12
β-amino acid substitution in the SIINFEKL antigen alters immunological recognition12
Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression12
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance12
CircSETD2 inhibits YAP1 by interaction with HuR during breast cancer progression12
CX43 down-regulation promotes cell aggressiveness and 5-fluorouracil-resistance by attenuating cell stiffness in colorectal carcinoma12
Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation12
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion11
Identification of coilin in bone marrow as a potential neuroblastoma tumor progression marker transcriptionally regulated by MYCN11
Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma11
MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer11
Association between the IL1B-511 C>T polymorphism and the risk of hematologic malignancies: data from a meta-analysis11
Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules11
Roles of TRPM channels in glioma11
MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway11
The human microbiome and cancer: a diagnostic and therapeutic perspective11
Correction11
Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression11
Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer11
NCAPD2 promotes the progression of lung adenocarcinoma through an AKT/MDM2/E2F1 positive feedback loop11
0.43146800994873